Kyverna Therapeutics, Inc.
USD9.13
+0.35 (+3.99%)
CEO
Warner Biddle
IPO Date
2024-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.78
Prev. Close
$8.78
Day Low
$8.65
Day High
$9.19
52W Low
$2.52
52W High
$13.67
Market Cap
$0.40B
Volume
0.38M
| -1.1 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -122.8% | -80.3% | 0.18 | 3.05 | -334.8 |
| 31 Dec 2022 | FY | 100.0% | -411.3% | -61.9% | -43.2% | 0.23 | 4.45 | -26.8 |
| 31 Dec 2021 | FY | 100.0% | -465.9% | 57.0% | -30.8% | -0.12 | 4.84 | -29.4 |
| -2.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -24.2% | -19.7% | 0.03 | 5.16 | -1.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -22.8% | -18.6% | 0.03 | 5.39 | -0.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -19.9% | -17.1% | 0.03 | 7.44 | -0.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -14.1% | -12.3% | 0.03 | 8.61 | -1.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -11.4% | -10.2% | 0.03 | 10.50 | -1.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -8.6% | -7.9% | 0.03 | 14.86 | -2.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -0.0% | -0.0% | 0.03 | 17.17 | -5010.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -42.0% | -27.5% | 0.18 | 3.05 | -15.6 |